Core Viewpoint - Figs reported a revenue of $151.83 million for Q4 2024, marking a 4.8% year-over-year increase, with an EPS of $0.01, which is a decrease from $0.05 a year ago, and exceeded the Zacks Consensus Estimate for revenue by 9.02% [1] Financial Performance - Revenue of $151.83 million represents a year-over-year increase of 4.8% [1] - EPS for the quarter was $0.01, compared to $0.05 a year ago [1] - The revenue surpassed the Zacks Consensus Estimate of $139.27 million by 9.02% [1] - The company did not deliver an EPS surprise, as the consensus EPS estimate was also $0.01 [1] Key Metrics - Active customers totaled 2,670, slightly below the four-analyst average estimate of 2,675 [4] - Average order value was $113, exceeding the four-analyst average estimate of $108.48 [4] - Net revenues per active customer were $208, compared to the $202.63 average estimate [4] - Geographic revenues from the Rest of the World reached $24.33 million, surpassing the $20.82 million average estimate, representing a 45.2% year-over-year increase [4] - Geographic revenues from the United States were $127.50 million, slightly below the two-analyst average estimate of $119.78 million, reflecting a -0.5% year-over-year change [4] - Revenues from Non-Scrubwear were $37.18 million, exceeding the $31.66 million estimated by two analysts, marking a 12.8% year-over-year increase [4] - Revenues from Scrubwear were $114.65 million, compared to the $108.88 million average estimate, representing a 2.4% year-over-year increase [4] Stock Performance - Shares of Figs returned +0.5% over the past month, while the Zacks S&P 500 composite experienced a -2.2% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Financial Data and Key Metrics Changes - Net revenues for Q4 increased by 5% year-over-year to $151.8 million, exceeding the implied outlook for the period [52] - Full year net revenue reached a record $555.6 million, an increase of 2% year-over-year [61] - Gross margin for Q4 contracted by 20 basis points to 67.3%, while full year gross margin contracted by 150 basis points to 67.6% [57][61] - Adjusted EBITDA for Q4 was $21.1 million, with an adjusted EBITDA margin of 13.9%, compared to 18.4% in the previous year [60] - The company ended the year with cash, cash equivalents, and short-term investments of $245.1 million, with no debt [62] Business Line Data and Key Metrics Changes - Scrubwear increased by 2%, representing 76% of net revenues for Q4, while non-scrubwear increased by 13%, representing 24% of net revenues [54][55] - The international business grew by 45% for the quarter, accounting for 16% of net revenues, marking an all-time high for the brand [16] Market Data and Key Metrics Changes - The company entered 10 new countries in 2024 and continued to scale in over 20 international markets [14] - The active customer base increased by 3% year-over-year to 2.7 million, while net revenues per active customer decreased by 1% to $208 [53] Company Strategy and Development Direction - The company plans to prioritize and rebase efforts, focusing on long-term brand health and reducing promotional activities [21][23] - There is a strategic shift towards enhancing product offerings, including the introduction of new fabric types and expanding into less developed categories like outerwear and footwear [30][28] - The company aims to deepen connections with healthcare professionals through a more authentic marketing approach and increased customization options [31][34] Management's Comments on Operating Environment and Future Outlook - Management acknowledged inconsistencies in performance throughout the year, citing challenges in customer acquisition and gross margin pressure [19][20] - The outlook for 2025 anticipates a decline in net revenues in the low single-digit range, reflecting headwinds from reduced promotions and potential declines in active customers [66] - Management expressed confidence in the long-term growth potential, emphasizing the importance of reinvigorating the U.S. business and expanding international and team channels [98] Other Important Information - The company repurchased $38.2 million worth of shares during the quarter, with approximately $4.6 million remaining under the previously announced share repurchase program [65] - The company has minimal direct exposure to tariffs from China, with indirect exposure from partners like New Balance [124] Q&A Session Summary Question: Plans to maintain and reengage lapsed customers during promotional reset - Management acknowledged headwinds on customer acquisition and plans to readjust promotional outlook while investing in brand awareness and retention efforts [80][81] Question: Insights on supply chain investments and pausing Canadian distribution center - Management indicated a focus on optimizing the current distribution facility and reassessing the roadmap for supply chain improvements [83] Question: Understanding the dynamic between strong Q4 performance and downbeat guidance for 2025 - Management explained that Q4 outperformance was driven by color launches, but headwinds in active customer growth and promotional shifts are expected to impact 2025 [92][93] Question: Building blocks to return to normalized growth - Management emphasized the need to reinvigorate growth in the U.S. business and active customer base while expanding retail and international channels [98] Question: Selling and G&A expense dynamics - Management discussed the normalization of transitory costs related to the new distribution center and the impact of increased fixed costs and international operations on selling expenses [106] Question: Profitability of international and non-scrubwear categories - Management confirmed that international operations are profitable, despite a different cost profile, and expects continued growth in non-scrubwear categories [111][112] Question: Product category opportunities and tariffs - Management highlighted ongoing innovation in product categories and minimal exposure to current tariff plans [124]

FIGS (FIGS) Q4 2024 Earnings Call February 28, 2025 04:27 AM ET Company Participants Tom Shaw - SVP of Investor RelationsTrina Spear - Co-Founder and CEOSarah Oughtred - CFOBrooke Roach - Vice President, Equity ResearchJohn Kernan - Managing DirectorDana Telsey - CEO and Chief Research OfficerLorraine Hutchinson - Managing DirectorAngus Kelleher-Ferguson - Equity Research AssociateNathan Feather - Equity Research Associate Conference Call Participants Brian Nagel - MD & Senior Analyst - Consumer Growth & eC ...

Figs (FIGS) came out with quarterly earnings of $0.01 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.05 per share a year ago. These figures are adjusted for non-recurring items.A quarter ago, it was expected that this health care apparel company would post a loss of $0.02 per share when it actually produced a loss of $0.01, delivering a surprise of 50%.Over the last four quarters, the company has surpassed consensus EPS estimates three times.Figs, which belongs to the ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________________________________________ FORM 10-K _________________________________________________________ (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Numb ...

FIGS Releases Fourth Quarter and Full Year 2024 Financial Results 2024 Results Exceed Expectations with Net Revenues Growth of 1.8% YoY, Net Income Margin of 0.5%, and Adjusted EBITDA Margin of 9.3% Increases Share Repurchase Authorization by $50 Million SANTA MONICA, Calif., February 27, 2025 — FIGS, Inc. (NYSE: FIGS) (the "Company"), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today released its fourth quarter and full year 2024 financial resul ...

In its upcoming report, Figs (FIGS) is predicted by Wall Street analysts to post quarterly earnings of $0.01 per share, reflecting a decline of 80% compared to the same period last year. Revenues are forecasted to be $139.27 million, representing a year-over-year decrease of 3.9%.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.Before a company announce ...

Private equity buyers are seeing value in the scrubs retailer.Shares of Figs (FIGS -3.85%) jumped this week after the company reportedly received a buyout offer for around $1 billion. In this video, Travis Hoium shows why private equity buyers may be interested and what the stock could do now.*Stock prices used were end-of-day prices of Dec. 11, 2024. The video was published on Dec. 12, 2024. ...

Long-only investment, evaluating companies from an operational, buy-and-hold perspective.Quipus Capital does not focus on market-driven dynamics and future price action. Instead, our articles focus on operational aspects, understanding the long-term earnings power of companies, the competitive dynamics of the industries where they participate, and buying companies that we would like to hold independently of how the price moves in the future. Most QC calls will be holds, and that is by design. Only a very sm ...

For the quarter ended September 2024, Figs (FIGS) reported revenue of $140.21 million, down 1.5% over the same period last year. EPS came in at -$0.01, compared to $0.03 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $144.11 million, representing a surprise of -2.71%. The company delivered an EPS surprise of +50.00%, with the consensus EPS estimate being -$0.02.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and ho ...